
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TORP | NSE | INR | Real-time | |
TORPc1:NS | NSE | INR | Delayed | |
TORPc2:NS | NSE | INR | Delayed | |
TORP | BSE | INR | Delayed |
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.
Name | Age | Since | Title |
---|---|---|---|
Nayantara Bali | 59 | 2019 | Independent Director |
Ameera Sushil Shah | 46 | 2018 | Independent Director |
Manish Mahendra Choksi | 58 | 2022 | Independent Director |
Nikhil Nirvan Khattau | 62 | 2023 | Independent Director |
Jinal Sudhirbhai Mehta | 42 | 2024 | Non-Executive Director |
Samir Uttamlal Mehta | 62 | 1989 | Chairman |
Aman Mehta | - | 2022 | MD & Whole-Time Director |
Sudhir Uttamlal Mehta | 71 | 2009 | Chairman Emeritus |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review